retatrutide liver is being talked about as the next big weight loss peptide. But a Victorian Government health warning over the weekend has linked products sold as 'Retatrutide' to six cases of acute retatrutide nonalcoholic fatty liver disease

Konig, M

Melanotic Macule of the Oral Mucosa Melanotic macules are one of the most common melanocytic lesions (48, 49) and lentigo simplex is the term used to describe a group of small and round macules (50)

While true cellulite can be challenging to address, much of what people mistake for cellulite is skin laxity caused by weight fluctuations, aging, or rapid weight loss from GLP-1 injections

They are the: Phase III study of Exenatide in Parkinsons study in the UK Phase II study of Lixisenatide in Parkinsons study in France (reporting results in late 2022) Phase II study of Semaglutide in Parkinsons study in Norway Phase II study of NLY01 in Parkinsons study across the USA (being conducted by Neuraly reporting results in 2023) Phase II study of PT320 in Parkinsons in South Korea (being conducted by Peptron -reporting results in 2022) Phase II study of Exenatide trial in Parkinsons in Sweden Phase I study of Exenatide in Parkinsons study in Florida The recently completed trial is a Phase II study investigating the effects of liraglutide in people with Parkinsons

How your body tolerates the medications will be the important factor